BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 3591059)

  • 21. [Radical surgery for ovarian cancer].
    Ochiai K; Takakura S; Kawashima M
    Gan To Kagaku Ryoho; 1992 Oct; 19(12):1977-81. PubMed ID: 1417006
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Second-look laparotomy after modified posterior exenteration: patterns of persistence and recurrence in patients with stage III and stage IV ovarian cancer.
    Spirtos NM; Eisenkop SM; Schlaerth JB; Ballon SC
    Am J Obstet Gynecol; 2000 Jun; 182(6):1321-7. PubMed ID: 10871445
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changing patterns of prognosticators during 15-year follow-up of advanced gastric cancer after radical gastrectomy and adjuvant chemotherapy: a 15-year follow-up study at a single korean institute.
    Moon YW; Jeung HC; Rha SY; Yoo NC; Roh JK; Noh SH; Kim BS; Chung HC
    Ann Surg Oncol; 2007 Oct; 14(10):2730-7. PubMed ID: 17632757
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of treatment failures and survival of patients with fallopian tube carcinoma: a cooperation task force (CTF) study.
    Gadducci A; Landoni F; Sartori E; Maggino T; Zola P; Gabriele A; Rossi R; Cosio S; Fanucchi A; Tisi G
    Gynecol Oncol; 2001 May; 81(2):150-9. PubMed ID: 11330942
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pseudomyxoma peritonei: a review of 23 cases.
    Wertheim I; Fleischhacker D; McLachlin CM; Rice LW; Berkowitz RS; Goff BA
    Obstet Gynecol; 1994 Jul; 84(1):17-21. PubMed ID: 8008316
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platin-based chemotherapy and salvage surgery in recurrent ovarian cancer following negative second-look laparotomy.
    Landoni F; Pellegrino A; Cormio G; Milani R; Maggioni A; Mangioni C
    Acta Obstet Gynecol Scand; 1998 Feb; 77(2):233-7. PubMed ID: 9512334
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Questioning current policies for the curative management of ovarian carcinoma.
    Fuks Z
    Isr J Med Sci; 1988; 24(9-10):572-9. PubMed ID: 3060447
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Standard of chemotherapy in ovarian cancer].
    Pfleiderer A; Meerpohl HG
    Chirurg; 1994 Jan; 65(1):18-22. PubMed ID: 8149794
    [No Abstract]   [Full Text] [Related]  

  • 29. Is there a role for second-look laparotomy in the management of malignant germ cell tumors of the ovary? Experience at Institut Gustave Roussy.
    Culine S; Lhomme C; Michel G; Leclere J; Duvillard P; Droz JP
    J Surg Oncol; 1996 May; 62(1):40-5. PubMed ID: 8618400
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Surgical treatment of ovarian cancer: comparison of primary and secondary tumor reduction interventions].
    Kuhn W; Jänicke F; Hölscher M; Schüle G; Pache L; Graeff H
    Gynakol Rundsch; 1991; 31 Suppl 2():276-80. PubMed ID: 1790953
    [No Abstract]   [Full Text] [Related]  

  • 31. [Second surgery in the management of ovarian cancer].
    Scarabelli C; Campagnutta E; Zarrelli A; De Piero G; Sopracordevole F; Visentin MC; Giorda G; Sasso GM; Parin A; Gallo A
    Minerva Ginecol; 1994; 46(1-2):5-13. PubMed ID: 8177464
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-dose melphalan-based chemotherapy and autologous stem cell transplantation after second look laparotomy in patients with chemosensitive advanced ovarian carcinoma: long-term results.
    Bertucci F; Viens P; Delpero JR; Bardou VJ; Faucher C; Houvenaeghel G; Maraninchi D
    Bone Marrow Transplant; 2000 Jul; 26(1):61-7. PubMed ID: 10918406
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ovarian cancer in the elderly: impact of surgery on morbidity and survival.
    Chéreau E; Ballester M; Selle F; Rouzier R; Daraï E
    Eur J Surg Oncol; 2011 Jun; 37(6):537-42. PubMed ID: 21511424
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Surgical management of malignant ovarian germ-cell tumors: 10 years' experience of 129 patients.
    Peccatori F; Bonazzi C; Chiari S; Landoni F; Colombo N; Mangioni C
    Obstet Gynecol; 1995 Sep; 86(3):367-72. PubMed ID: 7651644
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The value of second-look laparotomy in ovarian cancer.
    Rubin SC
    Oncology (Williston Park); 1987 Oct; 1(8):45-51. PubMed ID: 3079491
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endometrial cancer in premenopausal women 45 years and younger.
    Gitsch G; Hanzal E; Jensen D; Hacker NF
    Obstet Gynecol; 1995 Apr; 85(4):504-8. PubMed ID: 7898824
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neoadjuvant chemotherapy with vincristine and cisplatin followed by radical hysterectomy and pelvic lymphadenectomy for FIGO stage IB bulky cervical cancer: a Gynecologic Oncology Group pilot study.
    Eddy GL; Manetta A; Alvarez RD; Williams L; Creasman WT
    Gynecol Oncol; 1995 Jun; 57(3):412-6. PubMed ID: 7774847
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Second-look laparotomy in ovarian cancer.
    Creasman WT
    Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S122-7. PubMed ID: 7835795
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Role of the second look in ovarian neoplasia].
    Sciannameo F; Ronca P; Madami C; Alberti D
    Minerva Ginecol; 1993 May; 45(5):235-40. PubMed ID: 8351061
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systematic pelvic and paraaortic lymphadenectomy at second-look laparotomy for ovarian cancer.
    Baiocchi G; Grosso G; di Re E; Fontanelli R; Raspagliesi F; di Re F
    Gynecol Oncol; 1998 May; 69(2):151-6. PubMed ID: 9600823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.